TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
LAB

Standard Biotools Inc

Healthcare · Medical Devices · —

0.73$ +2.9% vs. previous close Closing price · As of: Sep 17, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Standard Biotools Inc (LAB) with date, type and a link to the original document.

Filings LAB
Date Type Filing Original
08/14/2026 Ownership disclosure Form SC 13G filed with the SEC View document ↗
08/05/2026 Current report (8-K) STANDARD BIOTOOLS INC. (LAB): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
07/28/2026 Current report (8-K) STANDARD BIOTOOLS INC. (LAB): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
07/24/2026 Current report (8-K) STANDARD BIOTOOLS INC. (LAB): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?